Cytochrome Life Sciences Private Limited, a active private limited company, was established on 20 October 2009 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2009PTC195361. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.49 M.
It upholds a compliant status. Employing 12 professional, Its leadership includes Tulika Anand Thakur (Director), Ashutosh Thakur (Managing Director). Past directors included Narendra Pratap Singh, Ashutosh Thakur, Yashpal Singh. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 15 January 2025, with the balance sheet filed on 31 March 2023. It is based at Property No. 46, Fie Patparganj Industrial Area, Delhi, Delhi, 110092.
U24232DL2009PTC195361
195361
20 October 2009
₹0.50 M
₹0.49 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cytochrome Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tulika Anand Thakur | Director | 04 Apr 2017 | Current |
| Ashutosh Thakur | Managing Director | 12 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Mar 2016 | Past |
| Pramod Abcsdd | Director | 30 Nov 2009 | Past |
| Pramod Abcsdd | Director | 18 Jul 2014 | Past |
| Pramod Abcsdd | Director | 18 Jul 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 22 Oct 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cytochrome Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 170.44% increase. The company also saw a substantial fall in profitability, with a 312.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Cytochrome Life Sciences had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2016 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Cytochrome Life Sciences has a workforce of 12 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cytochrome Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytochrome Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cytochrome Life Sciences Private Limited last Annual general meeting of members was held on 15 Jan 2025 as per latest MCA records. was recorded as a recent event.
The activity Cytochrome Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.
Progress on Tulika Anand Thakur was appointed as a Director was appointed as a Director on 04 Apr 2017 & has been associated with this company since 8 years 8 months . was documented.
Progress on A charge with Others amounted to Rs. 1.00 M with Charge ID 100104702 was registered on 14 Oct 2016. was documented.
Progress on Ashutosh Thakur was appointed as a Managing Director was appointed as a Managing Director on 12 May 2011 & has been associated with this company since 14 years 6 months . was documented.
Cytochrome Life Sciences Private Limited was registered on 20 Oct 2009 with Roc Delhi & aged 16 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Cytochrome Life Sciences Private Limited is U24232DL2009PTC195361.
Cytochrome Life Sciences Private Limited is headquartered at Property No. 46, Fie Patparganj Industrial Area, Delhi, Delhi, 110092.
Cytochrome Life Sciences Private Limited was incorporated on 20 October 2009.
The current directors of Cytochrome Life Sciences Private Limited are
The primary industry of Cytochrome Life Sciences Private Limited is Trade.
Cytochrome Life Sciences Private Limited is unlisted.
The authorized capital of Cytochrome Life Sciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.49 M.
The compliance status of Cytochrome Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX